MINNEAPOLIS, Dec. 12, 2022 /PRNewswire/ -- Smiths Medical issued an Urgent Medical Device Correction Letter to notify affected customers of two potential issues with CADD TM Infusion System Infusion ...
ST. PAUL, Minn.--(BUSINESS WIRE)--Smiths Medical, a leading global medical device manufacturer, announced today it has received FDA 510(k) clearance to market its CADD ®-Solis pain management system ...
A medical device correction has been issued by Smiths Medical for its CADD-Solis and CADD-Solis VIP infusion pumps due to software issues. The recall, which involves correcting devices and not ...
Epoprostenol (FLOLAN) is an intravenous medication used to treat primary pulmonary hypertension (PPH), a condition characterized by progressive increases in pulmonary artery pressure, leading to right ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback